COH Stock Overview
Provides implantable hearing solutions for children and adults worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for COH from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Cochlear Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$289.08 |
| 52 Week High | AU$350.31 |
| 52 Week Low | AU$272.75 |
| Beta | 0.46 |
| 1 Month Change | -2.99% |
| 3 Month Change | 2.33% |
| 1 Year Change | -2.05% |
| 3 Year Change | 33.75% |
| 5 Year Change | 24.23% |
| Change since IPO | 9,699.32% |
Recent News & Updates
Earnings Not Telling The Story For Cochlear Limited (ASX:COH)
Dec 20
Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Nov 19Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 04We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package
Oct 18Recent updates
Earnings Not Telling The Story For Cochlear Limited (ASX:COH)
Dec 20Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Nov 19Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 04We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package
Oct 18Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit
Sep 19Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next
Aug 16Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital
Aug 01Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Jun 08Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Mar 27Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Feb 21Shareholder Returns
| COH | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -0.8% | -1.1% | -2.7% |
| 1Y | -2.1% | 0.4% | 6.5% |
Return vs Industry: COH underperformed the Australian Medical Equipment industry which returned 0.4% over the past year.
Return vs Market: COH underperformed the Australian Market which returned 6.5% over the past year.
Price Volatility
| COH volatility | |
|---|---|
| COH Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: COH has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: COH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 5,047 | Dig Howitt | www.cochlear.com |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Cochlear Limited Fundamentals Summary
| COH fundamental statistics | |
|---|---|
| Market cap | AU$18.92b |
| Earnings (TTM) | AU$356.80m |
| Revenue (TTM) | AU$2.24b |
53.0x
P/E Ratio8.5x
P/S RatioIs COH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COH income statement (TTM) | |
|---|---|
| Revenue | AU$2.24b |
| Cost of Revenue | AU$562.10m |
| Gross Profit | AU$1.67b |
| Other Expenses | AU$1.32b |
| Earnings | AU$356.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 5.45 |
| Gross Margin | 74.86% |
| Net Profit Margin | 15.96% |
| Debt/Equity Ratio | 0% |
How did COH perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield75%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 02:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cochlear Limited is covered by 30 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | ANZ Equities Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Stuart Roberts | Bell Potter |